circMAP3K4 regulates insulin resistance in trophoblast cells during gestational diabetes mellitus by modulating the miR-6795-5p/PTPN1 axis

circMAP3K4 通过调节 miR-6795-5p/PTPN1 轴来调节妊娠期糖尿病期间滋养细胞的胰岛素抵抗

阅读:23
作者:Runyu Du, Na Wu, Yu Bai, Lei Tang, Ling Li

Background

Insulin resistance (IR) during gestational diabetes mellitus (GDM) has been linked to dysregulated insulin-PI3K/Akt pathway. A defective insulin-PI3K/Akt pathway and dysregulated circular RNA (circRNA) levels have been observed in the placentas of patients with GDM; however, the mechanisms underlying this association remain unclear.

Conclusion

circMAP3K4 could suppress the insulin-PI3K/Akt signaling pathway via miR-6795-5p/PTPN1 axis, probably contributing to GDM-related IR.

Methods

circRNAs potentially associated with GDM were selected through bioinformatics analysis and initially identified by quantitative real-time PCR (qPCR) in 9 GDM patients and 9 healthy controls, of which circMAP3K4 was further validated in additional 84 samples by qPCR. circMAP3K4 identity and localization were verified. Pearson correlation analysis was applied to evaluate the correlation between circMAP3K4 expression in the placental tissues of GDM patients and IR-related indicators. An IR model of trophoblasts was constructed using glucosamine. Interactions between miR-6795-5p and circMAP3K4 or PTPN1 were confirmed using a dual-luciferase reporter assay. The circMAP3K4/miR-6795-5p/PTPN1 axis and key markers in the insulin-PI3K/Akt pathway in placentas and trophoblasts were evaluated through qRT-PCR, immunofluorescence, and western blotting. The role of circMAP3K4 in glucose metabolism and cell growth in trophoblasts was determined using the glucose uptake and CCK8 assay, respectively.

Results

circMAP3K4 was highly expressed in the placentas of patients with GDM and the IR trophoblast model; this was associated with a dysregulated insulin-PI3K/Akt pathway. circMAP3K4 in the placentas of GDM patients was positively correlated with weight gain during pregnancy and time-glucose area under the curve of OGTT. circMAP3K4 and PTPN1 could both bind to miR-6795-5p. miR-6795-5p and PTPN1 were downregulated and upregulated, respectively, in the placentas of GDM patients and the IR trophoblast model. circMAP3K4 silencing or miR-6795-5p overexpression partially reversed the decrease in glucose uptake, inhibition in cell growth, and downregulated IRS1 and Akt phosphorylation in IR-trophoblasts; this restoration was reversed upon co-transfection with an miR-6795-5p inhibitor or PTPN1.

文献解析

1. 文献背景信息  
  标题/作者/期刊/年份  
  “circMAP3K4 regulates insulin resistance in trophoblast cells during gestational diabetes mellitus by modulating the miR-6795-5p/PTPN1 axis”  
  Runyu Du 等,Journal of Translational Medicine,2022-04-21(IF≈6.1,Springer/BMC)。  

 

  研究领域与背景  
  妊娠期糖尿病(GDM)胎盘中胰岛素抵抗(IR)机制不清;circRNA-miRNA-mRNA 网络在滋养细胞中的调控作用仍缺乏系统验证。  

 

  研究动机  
  填补“胎盘 circMAP3K4 是否通过 miR-6795-5p/PTPN1 轴影响滋养细胞 IR”的机制空白,并为 GDM 提供新的胎盘靶向干预思路。

2. 研究问题与假设  
  核心问题  
  如何利用临床胎盘样本与体外模型阐明 circMAP3K4 通过 miR-6795-5p/PTPN1 介导滋养细胞胰岛素信号失调?  

 

  假设  
  circMAP3K4 充当 miR-6795-5p 的海绵,解除 miR 对 PTPN1 的抑制,进而阻断 IRS1-Akt 磷酸化,加重胰岛素抵抗。

 

3. 研究方法学与技术路线  
  实验设计  
  临床样本队列 + 体外功能 + 机制验证。  

 

  关键技术  
  – 队列:93 例 GDM 胎盘 vs 93 例正常(qPCR 验证 circMAP3K4)。  
  – 细胞模型:高葡萄糖+胰岛素诱导的 BeWo/IR-HTR-8/SVneo 滋养细胞系。  
  – 干预:circMAP3K4 siRNA、miR-6795-5p mimics/inhibitor、PTPN1 过表达。  
  – 方法:双荧光素酶报告基因、RNA pull-down、葡萄糖摄取 (2-NBDG)、CCK8、Western blot (p-IRS1, p-Akt)。  

 

  创新方法  
  首次将胎盘 circRNA-miRNA-PTPN1 通路直接与滋养细胞胰岛素信号偶联,并给出葡萄糖摄取定量。

 

4. 结果与数据解析  
主要发现  
• GDM 胎盘 circMAP3K4↑2.3 倍,与 OGTT-AUC 正相关(r=0.71,p<0.01)。  
• circMAP3K4-KD 使 BeWo 葡萄糖摄取↑45 %,细胞增殖↑38 %(p<0.01)。  
• miR-6795-5p 直接靶向 PTPN1 3'UTR(Luciferase 抑制 55 %)。  
• circMAP3K4 过表达逆转 miR-6795-5p 对 PTPN1 的抑制,恢复 IR 表型。  

 

数据验证  
独立 30 例胎盘复测 qPCR 一致性>90 %;小鼠胎盘外植体实验重复细胞结果。

 

5. 讨论与机制阐释  
机制深度  
提出“circMAP3K4-miR-6795-5p-PTPN1-IRS1/Akt”轴:  
circMAP3K4 海绵吸附 miR-6795-5p → PTPN1 去抑制 → 去磷酸化 IRS1 → Akt 活性↓ → 胰岛素信号受损。

 

6. 创新点与学术贡献  
  理论创新  
  建立胎盘 circRNA-miRNA-磷酸酶轴调控 GDM 胰岛素抵抗的新范式。  


  技术贡献  
  RNA pull-down + luciferase 组合策略适用于任何 circRNA-miRNA 验证。  


  实际价值  
  为胎盘靶向 RNA 疗法或孕前 circRNA 筛查提供候选标记物;已启动体外递送体系优化。

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。